Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2003) 5 P269

BES2003 Poster Presentations Thyroid (27 abstracts)

Somatostatin receptor expression in thyroid disease

RJA England 1 , KJ Bedford 2,3 , L Karsai 3 & SL Atkin 2


1Department of ENT, Hull Royal Infirmary, UK; 2Department of Medicine, Hull Royal Infirmary, UK; 3Department of Pathology, Hull Royal Infirmary, UK.


Introduction: Somatostatins are physiological down regulatory proteins that act via 5 different transmembrane receptors (SSTR1-5, including isoforms SSTR-2a & 2b) via GTP binding proteins. The aim of this study was to determine the distribution of somatostatin receptors in thyrocytes of different thyroid pathologies.
Method: Formalin fixed paraffin embedded sections from archival tissue were immunostained. Sections underwent dewaxing and rehydration before microwave antigen retieval, followed by blocking. Sections were incubated overnight at 4oC in primary antibody diluted at 1:10000. Followed by secondary antibody, streptavidin-biotin-peroxidase, amplification and streptavidin-peroxidase. Staining was then visualised with diaminobenzadine.
Results: The number of sections expressing positive SSTR subtype staining in relation to type of thyroid pathology. Follicular adenoma (n=10): SSTR-1 8/10, SSTR-2A 9/10, SSTR-2B 10/10, SSTR-3 10/10, SSTR-4 9/10, SSTR-5 8/10. Hashimotos thyroiditis (n=5): SSTR-1 4/5, SSTR-2a 5/5, SSTR-2B 5/5, SSTR-3 4/5, SSTR-4 4/5, SSTR-5 5/5. Reidels thyroiditis (n=1): SSTR-1 1/1, SSTR-2a 1/1, SSTR-2b 1/1, SSTR-3 1/ 1, SSTR-4 1/1, SSTR-5 1/1. Papillary carcinoma (n=6): SSTR-1 5/6, SSTR-2a 4/6, SSTR-2b 5/6, SSTR-3 5/6, SSTR-4 5/6, SSTR-5 6/6. Graves disease (n=2): SSTR-1 2/2, SSTR-2a 1/2, SSTR-2b 2/2, SSTR-3 2/2, SSTR-4 2/2. SSTR-5 2/2. Anaplastic carcinoma (n=1): SSTR-1 1/1, SSTR-2a 1/1, SSTR-2b 1/1, SSTR-3 1/1, SSTR-4 1/1, SSTR-5 0/1. Follicular carcinoma (n=1): SSTR-1 1/1, SSTR-2a 1/1, SSTR-2b 1/1, SSTR-3 0/1, SSTR-4 1/1, SSTR-5 1/1. Multinodular goitre (n=17): SSTR-1 15/17, SSTR-2a 14/17, SSTR-2b 16/17, SSTR-3 14/17, SSTR-4 14/17, SSTR-5 16/17.
Conclusion: This preliminary data suggests that the SSTRs are widely distributed in thyroidal pathology and their role needs to be defined.

Volume 5

22nd Joint Meeting of the British Endocrine Societies

British Endocrine Societies 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts